Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholder's Equity (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statement of Changes in Stockholder's Equity (Unaudited) - USD ($)
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Balance - January 1, 2023 at Dec. 31, 2022   $ 365   $ (46,355)   $ 139,159,811   $ (10,842,569)   $ (117,479,571) $ 10,791,681
Balance, shares at Dec. 31, 2022   36,534   3                
Stock-based compensation:                        
Options       38,834       38,834
Restricted stock units       79,422       79,422
Restricted stock units, shares   39                    
Common stock issued for 401(k) employer matching   $ 3     32,614       32,617
Common stock issued for 401(k) employer matching, shares   242                    
Common stock issued for cash in private placement   $ 59     590,941       591,000
Common stock issued for cash in private placement, shares   5,910                    
Net loss           (2,695,148) (2,695,148)
Other comprehensive loss         (39,799)     (39,799)
Cumulative effect of change upon adoption of ASU 2016-13         $ (111,582)   (111,582)  
Shares issued under the New ELOC, net of offering costs [1]   $ 37     441,372       441,409
Shares issued under the New ELOC, net of offering costs, shares [1]   3,644                    
Relative fair value of warrants issued with 2023 Notes, net of issuance costs [2]       1,506,319       1,506,319
Warrants issued for modification of GGH Notes       134,779       134,779
Reduction of warrant exercise price on new debt issuance       63,502       63,502
Shares issued upon conversion  of debt and interest   $ 83     1,571,470       1,571,553
Shares issued upon conversion of debt and interest, shares   8,333                    
Cashless warrant exercise   $ 5     (5)      
Cashless warrant exercise, shares   513                    
True-up adjustment            
True-up adjustment, shares   3                    
Balance - March 31, 2023 at Mar. 31, 2023   $ 552   $ (46,355)   143,619,059   (10,882,368)   (120,286,301) 12,404,587
Balance, shares at Mar. 31, 2023   55,218   3                
Balance - January 1, 2023 at Dec. 31, 2023   $ 4,808   $ (46,355)   150,631,395   (11,104,706)   (133,789,163) 5,695,979
Balance, shares at Dec. 31, 2023   480,794   3                
Stock-based compensation:                        
Options       17,911       17,911
Restricted stock units   $ 19     74,747       74,766
Restricted stock units, shares   1,841                    
Common stock issued for 401(k) employer matching   $ 35     14,733       14,768
Common stock issued for 401(k) employer matching, shares   3,497                    
Common stock issued for cash in private placement   $ 2,888     1,730,046       1,732,934
Common stock issued for cash in private placement, shares   288,824                    
Net loss           (2,733,646) (2,733,646)
Other comprehensive loss         (36,391)     (36,391)
Balance - March 31, 2023 at Mar. 31, 2024   $ 7,750   $ (46,355)   $ 152,468,832   $ (11,141,097)   $ (136,522,809) $ 4,766,321
Balance, shares at Mar. 31, 2024   774,956   3                
[1] Includes gross proceeds of $480,670, less $39,261 offering costs.
[2] Represents $1,609,935 relative fair value of warrants, less $103,616 of allocable issuance costs.